Health Economia Life-Sciences Investment Series October 2022 Successfully investing in early life science assets, such as medical device projects, diagnostics, digital therapeutics or drug therapies, requires conducting thorough scientific due diligence, monitoring the development plan execution, and implementing a development risk assessment & mitigation plan. Besides the challenging environment, we observed that this era is appropriate to successfully invest in Life Science assets. After interacting with several Biotech founders, we consistently observed that they need the investors' advice and network, as much as the funds.
On 21 Sept 2022, the BIDMC team published the results […]
There is no better advice than this simple one: work […]